We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Ampronix,  Inc

Download Mobile App




Illustration

Patients Who Survive COVID-19 May Have Long-Term Brain Deficits

To date, the focus on COVID-19 patients has been more on keeping them alive and less on examining the impact the disease on their long-term health, although neurological issues in patients who suffer from COVID-19 call for better assessments to shape treatments. More...
05 Jun 2020
Image: This is a microscopic photo of a blood smear from a transgenic mouse that mimics the human immune disorder, secondary HLH (Photo courtesy of Cincinnati Children’s Hospital Medical Center)

Transgenic Mouse That Models Immune Disease’s Cytokine Storms Could Point to Treatment Solution for COVID-19

A transgenic mouse developed at Cincinnati Children’s Hospital Medical Center (Cincinnati, OH, USA) to model the deadly childhood immune disease HLH (hemophagocytic lymphohistiocytosis) could play a key role in saving lives during the COVID-19 virus pandemic. More...
05 Jun 2020
Radcal
Image: Scientists Create Important New Tool for Developing COVID-19 Treatments, Vaccines (Photo courtesy of Marcin Minor).

Scientists Create Important New Tool for Developing COVID-19 Treatments, Vaccines

Structural biologists at University of Virginia School of Medicine (Charlottesville, VA, USA) have developed a new tool to help biomedical scientists working with COVID-19 better understand the virus and feel confident about the structural models they are using in their research. More...
05 Jun 2020
Illustration

Ultra-Rare, Highly Potent SARS-CoV-2 Neutralizing Antibodies Identified for Development as COVID-19 Immunotherapy

Memo Therapeutics AG {(MTx) Schlieren, Switzerland} has identified several SARS-CoV-2-specific virus-neutralizing antibodies with the potential for development as a COVID-19 immunotherapy. More...
05 Jun 2020
Image: Roche Secures FDA Emergency Use Authorization for Elecsys IL-6 Test in COVID-19 Patients (Photo courtesy of Roche)

Roche Secures FDA Emergency Use Authorization for Elecsys IL-6 Test in COVID-19 Patients

Roche (Basel, Switzerland) has secured Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for its new Elecsys IL-6 test which measures levels of the biomarker interleukin 6 (IL-6). More...
05 Jun 2020
Image: First Patient Dosed with Cancer Drug Bemcentinib in COVID-19 Trial (Photo courtesy of BerGenBio ASA)

First Patient Dosed with Cancer Drug Bemcentinib in COVID-19 Trial

Dosing of bemcentinib has commenced in the UK government-backed Phase II clinical trial for assessing the cancer drug in hospitalized COVID-19 patients. More...
04 Jun 2020
Image: Brain Magnetic Resonance Imaging Alterations in a Patient with Coronavirus Disease 2019 (Photo courtesy of JAMA Network)

MRI Scan Reveals 'Viral Brain Invasion' of Coronavirus

Doctors have found magnetic resonance imaging (MRI) evidence of the ability of the novel coronavirus (SARS-CoV-2) to invade the brain based on brain scans of a COVID-19 patient with loss of taste and smell. More...
04 Jun 2020
Copyright © 2000-2020 Globetech Media. All rights reserved.